cdsco - IMSDA

CDSCO 2026 Overhaul: GMP Audits Outsourced, 1,500 Experts Hired as India Tightens Pharma Quality Standards

Post published:June 3, 2026
Post category:News

The Central Drugs Standard Control Organization (CDSCO) is undertaking its most significant regulatory transformation in decades. In a series of reforms announced in early 2026, India's drug regulator has unveiled…

WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You

Post published:June 2, 2026
Post category:Knowledge

🔬 WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You India supplies approximately 20% of the world's generic medicines by volume, making it the largest…

CDSCO 2026 Reforms: Prior Intimation, GMP Audits & Faster Drug Approvals

Post published:June 1, 2026
Post category:News

The Central Drugs Standard Control Organization (CDSCO), India's national drug regulatory authority, has undertaken the most significant regulatory modernization in its history during the first half of 2026. From introducing…

How to Verify the Quality of Indian Generic Medicines: A Buyer’s Guide

Post published:May 29, 2026
Post category:Knowledge

India is the largest supplier of generic medicines in the world, exporting over USD 50 billion worth of pharmaceuticals annually. Indian generics fill approximately 40% of the US generic drug…